Literature DB >> 34077640

Vaccine Breakthrough Infections with SARS-CoV-2 Variants.

Douglas F Nixon1, Lishomwa C Ndhlovu1.   

Abstract

Entities:  

Year:  2021        PMID： 34077640     DOI： 10.1056/NEJMc2107808

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.

Authors:  Shelan Liu; Min Kang; Na Zhao; Yali Zhuang; Shijian Li; Tie Song
Journal:  Med Rev (Berl)       Date:  2022-05-25

2.  Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination.

Authors:  Ariel Israel; Eugene Merzon; Yotam Shenhar; Ilan Green; Avivit Golan-Cohen; Alejandro A Schäffer; Eytan Ruppin; Shlomo Vinker; Eli Magen
Journal:  Vaccines (Basel)       Date:  2022-04-19

3.  Incidence and severity of COVID-19 infection post-vaccination: a survey among Indian doctors.

Authors:  Apurve Parameswaran; Sunil Apsingi; Krishna Kiran Eachempati; Chandra Sekhar Dannana; Ganshyam Jagathkar; Meenakshi Iyer; Harshita Aribandi
Journal:  Infection       Date:  2022-02-07       Impact factor: 7.455

4.  Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.

Authors:  Maxime Taquet; Quentin Dercon; Paul J Harrison
Journal:  Brain Behav Immun       Date:  2022-04-18       Impact factor: 19.227

5.  Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses.

Authors:  Vito Carlo Alberto Caponio; Maria Rosaria Lipsi; Francesca Fortunato; Fabio Arena; Lorenzo Lo Muzio
Journal:  Int J Environ Res Public Health       Date:  2022-01-13       Impact factor: 3.390

6.  Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.

Authors:  Jong Eun Lee; Minhee Hwang; Yun-Hyeon Kim; Myung Jin Chung; Byeong Hak Sim; Kum Ju Chae; Jin Young Yoo; Yeon Joo Jeong
Journal:  Radiology       Date:  2022-02-01       Impact factor: 29.146
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.